References

Agbenyega, T., Planche, T., Bedu-Addo, G., Ansong, D., Owusu-Ofori, A., Bhattaram, V.A., Nagaraja, N.V., Shroads, A.L., Henderson, G.N., Hutson, A.D., Derendorf, H., Krishna, S., Stacpoole, P.W. (2003). "Population kinetics, efficacy, and safety of Dichloroacetate for lactic acidosis due to severe malaria in children." Journal of Clinical Pharmacology. 43, 386–396.

Agresti, A. (1980). "Generalized odds ratios for ordinal data." Biometrics. 36, 59–67.

Feynman, R.P. (1999). The Pleasure of Finding Things Out. Cambridge, MA: Perseus Books.

Holloway, P.A., Knox, K., Bajaj, N., Chapman, D., White, N.J., O'Brien, R., Stacpoole, P.W., Krishna, S. (1995). "Plasmodium Berghei infection: Dichloroacetate improves survival in rats with lactic acidosis." Experimental Parasitology. 80, 624–632.

Ioannidis, J.P.A. (2005a). "Contradicted and Initially Stronger Effects in Highly Cited Clinical Research." JAMAM. 294, 218–228.

Ioannidis, J.P.A. (2005b). "Why Most Published Research Findings Are False." PLoS Medicine. 2, 696–701.

Johnson, N.L., Kotz, S., Balakrishnan, N. (1994). Continuous Univariate Distributions, Vol. 1 (2nd Ed.). New York: John Wiley.

Lee, S.J., Zelen, M. (2000). "Clinical trials and sample size considerations: Another perspective." Statistical Science. 15, 95–100.

SAS Institute Inc. (2006). SAS/STAT User's Guide. Cary, NC: SAS Institute Inc.

Stacpoole, P.W., Nagaraja, N.V., Hutson, A.D. (2003). "Efficacy of dichloroacetate as a lactate-lowering drug." Journal of Clinical Pharmacology. 43, 683–691.

Topol, E.J., Califf, R.M., Van de Werf, F., Simoons, M., Hampton, J., Lee, K.L., White, H., Simes, J., Armstrong, P.W. (1997). "Perspectives on large-scale cardiovascular clinical trials for the new millennium." Circulation. 95, 1072–1082.

Wacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., Rothman, N. (2004). "Assessing the probability that a positive report is false: An approach for molecular epidemiological studies." Journal of the National Cancer Institute. 96, 434–442.